Class III Medical Device Designation by MFDS

MDD Digital Therapeutics
BlueKare MFDS Certificated

Learn More
0+
Digital Healthcare Solutions
0+
Hospital Partners
0K+
Cumulative Users
0
MDFS Approved
What We Do

Featured Solutions

Solving mental health challenges with evidence-based digital therapeutics

BlueKare

BlueKare

Korea's first digital therapeutic for depression approved by the MFDS. A personalized 8-week program helps patients manage depression and anxiety on their own in everyday life.

Learn More
MHA+

MHA+

A psychological assessment tool developed by Hippo T&C. Optimized questions analyze five positive indicators (stability, self-esteem, vitality, connectedness, growth) and three negative indicators (depression, anxiety, stress), then suggest tailored solutions.

Learn More
CogMo Solution

CogMo Solution

A VR-based program that assesses children's cognitive and behavioral abilities through missions and applies personalized training based on the results. Children build up training effects naturally while playing.

Learn More
View All Solutions
Latest

News

Press Release April 24, 2026

Hope for Patients with Depression

#BlueKare#Prescription#NewHealthTechnology
Press Release April 17, 2026

Digital Wellness Association–Ewha Medical Academy 'Leaders Forum' Successfully Concluded

#DigitalWellnessAssociation#LeadersForum#CEOTaiMyoungChung
Notice June 17, 2025

Sang-Ho Lee of Hippo T&C Selected for Oral Presentation at AAAI 2025

#AAAI
Notice July 2, 2024

Hippo T&C Meets with UNMC Psychiatry Professors to Discuss Collaboration

#UNMC#Hippo T&C#Collaboration
View All

Looking for partners to build the future of digital therapeutics together

We welcome collaboration with hospitals, companies, and research institutions

All Partnerships Contact Us